K Pharma,Inc. Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	7,987	7,206	8,355	-	-
Market Cap Growth	5.73%	-13.75%	-	-	-
Enterprise Value	6,483	4,691	6,443	-	-
Last Close Price	688.00	621.00	720.00	-	-
PE Ratio	-	-	32.14	-	-
PS Ratio	-	-	8.36	-	-
PB Ratio	5.07	3.19	2.69	-	-
P/TBV Ratio	5.07	3.19	2.69	-	-
P/FCF Ratio	-	-	18.78	-	-
P/OCF Ratio	-	-	18.40	-	-
EV/Sales Ratio	-	-	6.44	-	-
EV/EBIT Ratio	-	-	17.56	-	-
EV/FCF Ratio	-	-	14.48	-	-
Asset Turnover	-	-	0.43	-	-
Inventory Turnover	-	-	9.00	-	-
Quick Ratio	20.60	36.00	18.35	40.49	8.17
Current Ratio	22.40	37.27	18.58	41.52	8.87
Return on Equity (ROE)	-44.53%	-31.55%	11.71%	-51.78%	-
Return on Assets (ROA)	-25.81%	-18.44%	9.79%	-27.94%	-
Return on Capital Employed (ROCE)	-54.90%	-36.50%	11.70%	-26.30%	-120.30%
Earnings Yield	-11.31%	-11.74%	3.11%	-	-
FCF Yield	-	-13.84%	5.33%	-	-
Buyback Yield / Dilution	-0.62%	-2.97%	-20.79%	-22.75%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.